Literature DB >> 6783655

Differential activation of platelet phospholipases by thrombin and ionophore A23187.

S Rittenhouse-Simmons.   

Abstract

Although exposure of platelets to ionophore A23187 causes some activation of phospholipase C, ionophore is an inefficient stimulus for this enzyme. A23187 induces the formation of one-fourth to one-sixth as much diglyceride as does thrombin when comparable amounts of phosphatidylinositol are hydrolyzed. We have shown previously that in the presence of indomethacin thrombin-treated platelets accumulate significant quantitites of diglyceride via inhibition of diglyceride lipase. However, a similar accumulation of diglyceride does not occur when ionophore is used as a stimulus in the presence of indomethacin. Ionophore does not appear to be stimulating the catabolism of diglyceride, since the simultaneous addition of ionophore and thrombin does not impair the formation and metabolism of diglyceride which is promoted by thrombin alone. Further, whereas indomethacin exerts no inhibitory effects upon phospholipase C or the formation of diglyceride in platelets responding to either stimulus, indomethacin does inhibit 1) the loss of arachidonic acid from phosphatidylcholine in response to thrombin and 2) the loss of arachidonic acid from phosphatidylcholine and phosphatidylinositol in response to A23187. We conclude that in A23187-activated platelets, phosphatidylinositol is hydrolyzed primarily by an enzyme other than phospholipase C. This indomethacin-inhibitable enzyme is probably a phospholipase A. Therefore, the full expression of phospholipase C in platelets requires more than a general flux in intracellular calcium.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6783655

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Effects of omega-3 fatty acids on vascular smooth muscle cells: reduction in arachidonic acid incorporation into inositol phospholipids.

Authors:  N R Yerram; A A Spector
Journal:  Lipids       Date:  1989-07       Impact factor: 1.880

Review 2.  The eicosanoids and their biochemical mechanisms of action.

Authors:  W L Smith
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

3.  Regulation of thromboxane receptor activation in human platelets.

Authors:  R Murray; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Inositol phospholipid arachidonic acid metabolism in GH3 pituitary cells.

Authors:  D T Dudley; A A Spector
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

5.  [Relation between post-thrombotic syndrome, ADP-induced thrombocyte aggregation and intrathrombocyte calcium content].

Authors:  B Heintz; C Femers; N Maurin; H Kierdorf; C Brilon; V Wienert
Journal:  Klin Wochenschr       Date:  1989-12-04

6.  Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.

Authors:  J A Ware; P C Johnson; M Smith; E W Salzman
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  Arachidonate mobilization in diacyl, alkylacyl and alkenylacyl phospholipids on stimulation of rat platelets by thrombin and the Ca2+ ionophore A23187.

Authors:  O Colard; M Breton; G Bereziat
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

8.  The role of calcium in the regulation of prostacyclin synthesis by porcine aortic endothelial cells.

Authors:  A R Whorton; C E Willis; R S Kent; S L Young
Journal:  Lipids       Date:  1984-01       Impact factor: 1.880

9.  Activation of human platelet phospholipase C by ionophore A23187 is totally dependent upon cyclo-oxygenase products and ADP.

Authors:  S E Rittenhouse
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

10.  Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets.

Authors:  D E MacIntyre; W K Pollock
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.